You just read:

Infinity Pharmaceuticals Announces the Initiation of Two Clinical Trials Evaluating IPI-549 in Novel Triple Combination Therapies for the Treatment of Solid Tumors

News provided by

Infinity Pharmaceuticals, Inc.

Sep 04, 2019, 08:32 ET